Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel PAI-1 inhibitor protects against vascular lesions

May 3, 1996

Ajinomoto reports on antihypertensive agent AP-1067

May 3, 1996

TAK-218 discussed at length at Japanese meetings

May 3, 1996

Tanabe's T-477 shows neuroprotective effects

May 3, 1996

Pola describes dopamine reuptake inhibitors for Parkinson's disease

May 3, 1996

KY-455: Kyoto Pharm.'s ACAT/lipid peroxidation inhibitor

May 3, 1996

Vertex dedicates significant efforts to MDR-reversing agents

May 3, 1996

Eisai presents preliminary data on ER-34335

May 3, 1996

Selectin inhibitor GSC-150 effective in dermatitis models

May 3, 1996

MM-218 selected for development in emesis, diarrhea

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....